XNYSAVD
Market cap144mUSD
Jan 16, Last price
5.02USD
1D
2.24%
1Q
-8.06%
Jan 2017
-73.79%
Name
American Vanguard Corp
Chart & Performance
Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, molluscicides, soil health, plant nutrition, growth regulators, and soil fumigants in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection. The company also markets, sells, and distributes end-use chemical and biological products for crop applications; and distributes chemicals for turf and ornamental markets. It distributes its products through national distribution companies, and buying groups or co-operatives; and through sales offices, sales force executives, sales agents, and wholly owned distributors. The company was incorporated in 1969 and is headquartered in Newport Beach, California.
IPO date
Mar 03, 1987
Employees
822
Domiciled in
US
Incorporated in
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 579,371 -4.96% | 609,615 9.47% | |||||||
Cost of revenue | 556,076 | 555,011 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 23,295 | 54,604 | |||||||
NOPBT Margin | 4.02% | 8.96% | |||||||
Operating Taxes | 2,778 | 8,561 | |||||||
Tax Rate | 11.93% | 15.68% | |||||||
NOPAT | 20,517 | 46,043 | |||||||
Net income | 7,519 -72.56% | 27,404 47.44% | |||||||
Dividends | (3,384) | (2,787) | |||||||
Dividend yield | 1.08% | 0.43% | |||||||
Proceeds from repurchase of equity | (17,506) | (34,405) | |||||||
BB yield | 5.59% | 5.31% | |||||||
Debt | |||||||||
Debt current | 12,162 | 5,279 | |||||||
Long-term debt | 179,207 | 95,740 | |||||||
Deferred revenue | |||||||||
Other long-term liabilities | 3,138 | 4,167 | |||||||
Net debt | 179,953 | 77,807 | |||||||
Cash flow | |||||||||
Cash from operating activities | (58,748) | 57,105 | |||||||
CAPEX | (12,064) | (14,554) | |||||||
Cash from investing activities | (17,017) | (14,470) | |||||||
Cash from financing activities | 66,737 | (38,260) | |||||||
FCF | (88,325) | 43,174 | |||||||
Balance | |||||||||
Cash | 11,416 | 20,328 | |||||||
Long term investments | 2,884 | ||||||||
Excess cash | |||||||||
Stockholders' equity | 330,401 | 320,007 | |||||||
Invested Capital | 547,404 | 450,394 | |||||||
ROIC | 4.11% | 10.19% | |||||||
ROCE | 4.20% | 11.74% | |||||||
EV | |||||||||
Common stock shares outstanding | 28,533 | 29,872 | |||||||
Price | 10.97 -49.47% | 21.71 32.46% | |||||||
Market cap | 313,007 -51.74% | 648,521 30.12% | |||||||
EV | 492,960 | 726,328 | |||||||
EBITDA | 46,829 | 76,742 | |||||||
EV/EBITDA | 10.53 | 9.46 | |||||||
Interest | 13,007 | 3,954 | |||||||
Interest/NOPBT | 55.84% | 7.24% |